Hycamtin

In the US, Hycamtin (topotecan systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Cancer, Cervical Cancer, Ovarian Cancer and Small Cell Lung Cancer.

US matches:

• Hycamtin


• Hycamtin Capsules


• Hycamtin Intravenous

UK matches:

• Hycamtin 0.25mg and 1 mg hard capsule (SPC)
• Hycamtin 1mg and 4mg powder for concentrate for solution for infusion (SPC)

Ingredient matches for Hycamtin

Topotecan

Topotecan is reported as an ingredient of Hycamtin in the following countries:

• Bulgaria


• Ireland


• Taiwan

Topotecan hydrochloride (a derivative of Topotecan) is reported as an ingredient of Hycamtin in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Canada


• Chile


• China


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Iran


• Israel


• Italy


• Japan


• Kuwait


• Luxembourg


• Netherlands


• Norway


• Oman


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Thailand


• Turkey


• United Arab Emirates


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.